These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 1632988)
1. [Pharmaceutical companies as sponsors of clinical trials--advantages and limitations]. Reis LL Rev Port Cardiol; 1992 Apr; 11(4):333-8. PubMed ID: 1632988 [TBL] [Abstract][Full Text] [Related]
2. [An analysis of the pharmaceuticals market in Vietnam]. Simonet D Sante; 2001; 11(3):155-60. PubMed ID: 11641078 [TBL] [Abstract][Full Text] [Related]
6. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research. Newcombe JP; Kerridge IH Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839 [TBL] [Abstract][Full Text] [Related]
7. The drug industry and clinical research in interwar America: three types of physician collaborator. Rasmussen N Bull Hist Med; 2005; 79(1):50-80. PubMed ID: 15764827 [TBL] [Abstract][Full Text] [Related]
8. Association of funding and findings of pharmaceutical research at a meeting of a medical professional society. Finucane TE; Boult CE Am J Med; 2004 Dec; 117(11):842-5. PubMed ID: 15589488 [TBL] [Abstract][Full Text] [Related]
9. [Organisation of clinical research in France: the new missions of inter-regional delegations for clinical research]. Jaillon P Bull Acad Natl Med; 2008 May; 192(5):929-37; discussion 937-9. PubMed ID: 19238783 [TBL] [Abstract][Full Text] [Related]
10. [The roles and responsibilities of the pharmaceutical industry]. Dejgaard A; Thomsen MK Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829 [TBL] [Abstract][Full Text] [Related]
11. [Clinical research and pharmaceutical industry. A relationship with advantages and disadvantages]. ten Cate JW; Büller HR Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1572-6. PubMed ID: 10443284 [TBL] [Abstract][Full Text] [Related]
12. Evaluating solutions to sponsorship bias. Doucet M; Sismondo S J Med Ethics; 2008 Aug; 34(8):627-30. PubMed ID: 18667655 [TBL] [Abstract][Full Text] [Related]
13. Beware the Medical-Industrial Complex. Stevens CW; Glatstein E Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005 [TBL] [Abstract][Full Text] [Related]
14. [Our policy and future tasks related to ICH in anti-cancer drug development--a discussion from the viewpoint of an enterprise]. Ekimoto H Gan To Kagaku Ryoho; 1997 Jan; 24(2):229-37. PubMed ID: 9030236 [TBL] [Abstract][Full Text] [Related]
16. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
19. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials. Peppercorn J; Blood E; Winer E; Partridge A Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054 [TBL] [Abstract][Full Text] [Related]